Navigation Links
DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
Date:9/24/2009

PRINCETON, N.J., Sept. 24 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.

Under the terms of the agreements, DOR will sell approximately 15,200,000 common shares together with a five-year warrant to purchase up to approximately 7,600,000 shares of DOR common stock at $0.278 per share, for an aggregate price of approximately $3.85 million ($0.253 per share representing the market price of DOR's common stock as measured by its five- day trailing average as of September 22, 2009). The expiration date of the warrants will be accelerated if the Company's common stock meets certain price thresholds and DOR would receive additional gross proceeds of approximately $2.11 million if exercised.

"We are pleased with this vote of confidence and support from our partner Sigma-Tau and the institutional investors," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of DOR. "This financing is designed to provide the fuel to complete our confirmatory Phase 3 clinical study of orBec(R) in the treatment of acute GI GVHD, an unmet medical need. We are looking forward to the imminent initiation of this trial."

The Company's common stock will be sold to accredited investors in a private placement in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The shares will not be registered under the Securities Act or any state securities laws, and the shares may not be offered or sold by the investors absent registration or an applicable exemption from the registration requirements of th
'/>"/>

SOURCE DOR BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
2. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
3. Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
4. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
5. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
6. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
7. CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
8. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
9. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
10. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... the position of Vice President, General Counsel and Corporate ... directly to Pat Mackin , President and Chief ... is tremendously talented and has extensive legal experience in ...
(Date:4/1/2015)... YORK , April 1, 2015  New York ... their world class Intellectual Properties portfolio with U.S. Patent ... Properties policy. This patent represents a surgical instrument that ... seeing as if it were in the traditional format ... match it against medical databases during surgery, thus providing ...
(Date:4/1/2015)... Ill. and ASPEN, Colo. ... in partnership with the Chris Klug Foundation (CKF), is pleased ... are now being accepted for the award, which will ... quality of life, whether it is a career accomplishment, ... a fulfilling life with family and loved ones. ...
Breaking Medicine Technology:CryoLife Appoints Jean Holloway as General Counsel 2CryoLife Appoints Jean Holloway as General Counsel 3Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3
... Reportlinker.com announces that a new market research report ... Dialysis Market -2013 http://www.reportlinker.com/p0289800/Global-Dialysis-Market-2009-2013.html ... Technavio Insights forecasts the Dialysis market to grow at ... America and Latin America) having the largest market share ...
... N.C., Sept. 7 VR Mergers & Acquisitions Charlotte ... of Charlotte, NC,s Amramp franchise, a provider of quality ... Charlotte Amramp serves over 50 counties in North Carolina ... largest franchisee in Amramp,s nationwide system. Rick ...
Cached Medicine Technology:Reportlinker Adds Global Dialysis Market -2013 2Reportlinker Adds Global Dialysis Market -2013 3
(Date:4/1/2015)... Royal River Natural Foods, a locally-owned independent ... that found the amino acid creatine, which athletes typically use ... blood pressure. , The report is part of ... Being® ,” which Royal River Natural Foods publishes each month ... learn the latest in nutrition science. Also in the April ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 The panel ... and telematics service providers to build a program that ... and complicated legal implications further down the line. This ... wake of the news that OBD-II port dongles aren’t ... In January, it was reported that Progressive’s Snapshot ...
(Date:4/1/2015)... 2015 Taking an important step forward ... for Nursing Commission for Nursing Education Accreditation (NLN CNEA) ... first NLN CNEA Board of Commissioners. Working with executive ... 15-member board will provide leadership and direction to accreditation ... decisions for nursing programs that seek accreditation from the ...
(Date:4/1/2015)... EAGAN, Minn. (April 1, 2015) —Blue Cross ... companies (Blue Cross) today announced audited financial results for ... income of $61.5 million, reflecting positive investment portfolio performance ... net operating loss of $8.2 million on full-year revenues ... one-tenth of one percent (0.1%). , Blue Cross ...
(Date:4/1/2015)... Diego, CA (PRWEB) April 01, 2015 ... organization, is announcing two continuing medical education (CME) ... is to help practitioners become more confident in ... prevent disease. After completion of these CME courses, ... , The CME courses available are “Vitamin ...
Breaking Medicine News(10 mins):Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3
... Quest Diagnostics Incorporated (NYSE: DGX ), the world,s ... it is scheduled to speak at the Jefferies 3rd Annual ... 2009. The Quest Diagnostics presentation is scheduled to begin at ... be webcast live during the conference and will be available ...
... of gene therapy suppresses tumors in mice , MONDAY, ... to fight lung cancer using gene therapy delivered by an ... cancer that were treated with a vaporized viral vector twice ... untreated mice. , Researchers also found that treated mice had ...
... ... certified to perform corneal transplants with the AlphaCor artificial cornea. , ... (Vocus) June 15, 2009 -- Eye ... perform corneal transplants with the AlphaCor artificial cornea. A shortage in donor corneas ...
... CancerTV Features On-Demand Videos from Oncologists, Academics, Institutions, ... , , BALTIMORE, June 15 CancerTV.com ... sharing site that demystifies cancer and treatments for ... Combining original programming with an interactive community and ...
... Action by Pledging to Improve Downstate NY,s Air Quality ... State Department of Transportation (NYSDOT) Acting Commissioner Stan Gee, in ... declared the week of June 15th "Commit to Cleaner Air" ... with local businesses, individuals and community partners, seeks to motivate ...
... (NYSE Amex: KAD ), which provides innovative consumer ... issue its fiscal fourth quarter and year-end financial results prior ... June 25, 2009. , , Arcadia will conduct ... financial results on Thursday, June 25, 2009, at 11:00 a.m. ...
Cached Medicine News:Health News:Coming Soon: Lung-Cancer Spray? 2Health News:Dr. Dean Dornic Certified to Perform Artificial Cornea Transplant 2Health News:Dr. Dean Dornic Certified to Perform Artificial Cornea Transplant 3Health News:Cancer Related Educational Video Sharing and Interactive Community Launches Online 2Health News:Cancer Related Educational Video Sharing and Interactive Community Launches Online 3Health News:New York State Department of Transportation and American Lung Association in New York Announce 'Commit to Cleaner Air' Week 2Health News:New York State Department of Transportation and American Lung Association in New York Announce 'Commit to Cleaner Air' Week 3Health News:Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth-Quarter and Year-End Conference Call 2
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Total Protein in serum and plasma...
Medicine Products: